Adicet Bio, Inc.
Symboli: ACET
NASDAQ
1.69
USDMarkkinahinta tänään
-0.5143
P/E-suhde
0.0002
PEG-suhde
138.87M
MRK Cap
- 0.00%
DIV Tuotto
Adicet Bio, Inc. (ACET) Tilinpäätöstiedotteet
Tase
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 780.07 | 159.7 | 257.7 | 277.5 | ||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.net-receivables | 1.23 | 0 | 0.4 | 0.2 | ||||||||||||||||
balance-sheet.row.inventory | 6.39 | 0 | 2.6 | 4.7 | ||||||||||||||||
balance-sheet.row.other-current-assets | 3.94 | 2.6 | 0.4 | 0 | ||||||||||||||||
balance-sheet.row.total-current-assets | 791.62 | 162.3 | 261 | 282.4 | ||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 188.76 | 44.2 | 49 | 35 | ||||||||||||||||
balance-sheet.row.goodwill | 38.92 | 0 | 19.5 | 19.5 | ||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 38.92 | 0 | 19.5 | 19.5 | ||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 0 | 0 | 0.1 | ||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | -0.1 | ||||||||||||||||
balance-sheet.row.other-non-current-assets | 3.85 | 0.8 | 1.2 | 2 | ||||||||||||||||
balance-sheet.row.total-non-current-assets | 231.54 | 45 | 69.7 | 56.5 | ||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-assets | 1023.16 | 207.3 | 330.7 | 338.9 | ||||||||||||||||
balance-sheet.row.account-payables | 12.56 | 2.6 | 4.4 | 3.3 | ||||||||||||||||
balance-sheet.row.short-term-debt | 12.34 | 3.2 | 2.5 | 1.6 | ||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.long-term-debt-total | 76.52 | 17.7 | 18.5 | 19.4 | ||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||
balance-sheet.row.other-current-liab | 51.09 | 13.4 | 12.8 | 6.7 | ||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 77.04 | 17.8 | 18.6 | 19.5 | ||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.capital-lease-obligations | 85.64 | 17.7 | 21 | 20.9 | ||||||||||||||||
balance-sheet.row.total-liab | 153.03 | 37.1 | 38.4 | 35.8 | ||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 338.9 | ||||||||||||||||
balance-sheet.row.common-stock | 0.02 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.retained-earnings | -1302.45 | -380.8 | -238.1 | -168.3 | ||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | 0 | -338.9 | ||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 1637.35 | 550.9 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-stockholders-equity | 334.92 | 170.2 | -238.1 | -168.3 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 487.95 | 207.3 | -199.8 | -132.5 | ||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||
balance-sheet.row.total-equity | 334.92 | 170.2 | -238.1 | -168.3 | ||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 487.95 | - | - | - | ||||||||||||||||
Total Investments | 0 | 0 | 0 | 0.1 | ||||||||||||||||
balance-sheet.row.total-debt | 88.86 | 20.9 | 21 | 20.9 | ||||||||||||||||
balance-sheet.row.net-debt | -691.21 | -138.8 | -236.6 | -256.6 |
Kassavirtalaskelma
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -142.66 | -142.7 | -69.8 | -62 | ||||||||||||||||
cash-flows.row.depreciation-and-amortization | 6.1 | 6.1 | 2.6 | 1.5 | ||||||||||||||||
cash-flows.row.deferred-income-tax | 9.71 | -34.1 | 0 | 1.2 | ||||||||||||||||
cash-flows.row.stock-based-compensation | 20.26 | 20.3 | 17.1 | 12.5 | ||||||||||||||||
cash-flows.row.change-in-working-capital | 0.25 | 0.3 | 2.7 | -6.1 | ||||||||||||||||
cash-flows.row.account-receivables | 0 | 0 | 0.2 | 0 | ||||||||||||||||
cash-flows.row.inventory | 0 | 0 | 0 | 2 | ||||||||||||||||
cash-flows.row.account-payables | -1.68 | -1.7 | 1.7 | 1.1 | ||||||||||||||||
cash-flows.row.other-working-capital | 1.94 | 1.9 | 0.8 | -9.2 | ||||||||||||||||
cash-flows.row.other-non-cash-items | 12.62 | 56.5 | 2.6 | 1.7 | ||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -93.72 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -4.46 | -4.5 | -16.8 | -13 | ||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 0 | 10.3 | ||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -4.46 | -4.5 | -16.8 | -2.8 | ||||||||||||||||
cash-flows.row.debt-repayment | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.common-stock-issued | 0.39 | 0.4 | 43.4 | 238.1 | ||||||||||||||||
cash-flows.row.common-stock-repurchased | -0.15 | -0.1 | -3.2 | 0 | ||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.other-financing-activites | 0.08 | -0.1 | -1.9 | 4.6 | ||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0.24 | 0.2 | 41.5 | 242.7 | ||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||||
cash-flows.row.net-change-in-cash | -97.94 | -97.9 | -20 | 188.8 | ||||||||||||||||
cash-flows.row.cash-at-end-of-period | 780.07 | 159.7 | 257.7 | 277.7 | ||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 878.01 | 257.7 | 277.7 | 88.9 | ||||||||||||||||
cash-flows.row.operating-cash-flow | -93.72 | -93.7 | -44.8 | -51.1 | ||||||||||||||||
cash-flows.row.capital-expenditure | -4.46 | -4.5 | -16.8 | -13 | ||||||||||||||||
cash-flows.row.free-cash-flow | -98.18 | -98.2 | -61.5 | -64.1 |
Tuloslaskelmarivi
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 0 | 25 | 9.7 | ||||||||||||||||
income-statement-row.row.cost-of-revenue | 8.14 | 6.1 | 5 | 0 | ||||||||||||||||
income-statement-row.row.gross-profit | -8.14 | -6.1 | 20 | 9.7 | ||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||
income-statement-row.row.research-development | 106.04 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-general-administrative | 26.53 | - | - | - | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | -1.69 | - | - | - | ||||||||||||||||
income-statement-row.row.other-expenses | -0.57 | 19.5 | -0.9 | -0.6 | ||||||||||||||||
income-statement-row.row.operating-expenses | 130.89 | 126.5 | 97.5 | 71.2 | ||||||||||||||||
income-statement-row.row.cost-and-expenses | 132.58 | 132.6 | 97.5 | 71.2 | ||||||||||||||||
income-statement-row.row.interest-income | 9.98 | 10 | 3.8 | 0.1 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.02 | 0 | 0.1 | 0.2 | ||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | -1.69 | - | - | - | ||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -15.21 | -10.1 | 2.8 | -0.7 | ||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||
income-statement-row.row.other-operating-expenses | -0.57 | 19.5 | -0.9 | -0.6 | ||||||||||||||||
income-statement-row.row.total-operating-expenses | -15.21 | -10.1 | 2.8 | -0.7 | ||||||||||||||||
income-statement-row.row.interest-expense | 0.02 | 0 | 0.1 | 0.2 | ||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 7.3 | 6.1 | 2.8 | -0.5 | ||||||||||||||||
income-statement-row.row.ebitda-caps | -120.41 | - | - | - | ||||||||||||||||
income-statement-row.row.operating-income | -152.04 | -132.6 | -72.6 | -61.4 | ||||||||||||||||
income-statement-row.row.income-before-tax | -142.66 | -142.7 | -69.8 | -62.1 | ||||||||||||||||
income-statement-row.row.income-tax-expense | -1.51 | 0 | -2.8 | -0.1 | ||||||||||||||||
income-statement-row.row.net-income | -141.4 | -142.7 | -67 | -62 |
Usein kysytty kysymys
Mikä on Adicet Bio, Inc. (ACET) taseen loppusumma?
Adicet Bio, Inc. (ACET) kokonaisvarat ovat 207295000.000.
Mikä on yrityksen vuotuinen liikevaihto?
Vuotuinen liikevaihto on N/A.
Mikä on yrityksen voittomarginaali?
Yrityksen voittomarginaali on 0.000.
Mikä on yrityksen vapaa kassavirta?
Vapaa kassavirta on -2.281.
Mikä on yrityksen nettovoittomarginaali?
Nettovoittomarginaali on 0.000.
Mikä on yrityksen kokonaistulot?
Kokonaisliikevaihto on 0.000.
Mikä on Adicet Bio, Inc. (ACET) nettovoitto (nettotulos)?
Nettovoitto (nettotulos) on -142658000.000.
Mikä on yrityksen kokonaisvelka?
Kokonaisvelka on 20924000.000.
Mikä on yrityksen toimintakulujen määrä?
Toimintakulut ovat 126478000.000.
Mikä on yrityksen kassan määrä?
Yrityksen kassavarat ovat 159711000.000.